Ventricular Tachycardia Mechanisms
ConditionVentricular Tachycardia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEmory University
About this trial
The purpose of this study is to understand why certain hearts have ventricular arrhythmias and help identify areas of the heart that cause arrhythmias. There is still a significant gap in understanding why ventricular arrhythmias occur. This study will examine the electrical properties of the heart tissue to understand how these arrhythmias occur, and hopefully identify areas that might lead to ventricular arrhythmias. The hope is that studying this might be able to improve outcomes during ventricular tachycardia (VT) ablations.
Eligibility criteria
Qualifiers
Diagnosis of ischemic cardiomyopathy
Single or dual chamber implantable cardioverter-defibrillator (ICD)
Disqualifiers
Non-Ischemic cardiomyopathy
Contraindication to catheter ablation
Severe peripheral arterial disease or medical condition that prohibit arterial access
Ventricular tachycardia (VT) or sudden cardiac arrest (SCA) within 30 days of acute coronary syndrome or within 90 days of coronary revascularization
Trial design
Treatments tested in this trial
- Monophasic Action Potential (MAP) Catheter
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov